SILVERARC CAPITAL MANAGEMENT, LLC Mirati Therapeutics, Inc. Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$2.96M
portfolio value

Mirati Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 call Decrease -57.88% -58.4K shares -3.80M $69.84 42.5K
Q3 2022 share Decrease -71.93% -26.18K shares -1.73M $69.84 10.22K
Q2 2022 call Increase 0.00% 100.9K shares 6.77M $67.13 100.9K
Q2 2022 share Decrease -21.07% -9.71K shares -1.34M $67.13 36.40K
Q1 2022 share Decrease -24.09% -14.63K shares -5.12M $82.22 46.12K
Q4 2021 share Increase +32.25% 14.81K shares 785K $148.23 60.75K
Q3 2021 share Increase +21.69% 8.18K shares 2.02M $176.91 45.94K
Q2 2021 share Increase +655.06% 32.75K shares 5.24M $161.53 37.75K
Q1 2021 share Decrease -75.00% -15K shares -3.53M $171.3 5K
Q4 2020 share Increase 0.00% 20K shares 4.39M $219.64 20K